Table1 Characteristics of locally advanced rectal cancer patients
From: Clinical predictors of pathological good response in locally advanced rectal cancer
Characteristics values | Counts |
|---|---|
Gender | |
Male | 103 |
Female | 70 |
Age (years, median [range]) | 56 (24–79) |
The distance from anal verge (cm, median [range]) | 5.3 (1–13.2) |
cT classification | |
2 | 10 |
3 | 69 |
4 | 94 |
cN classification | |
0 | 7 |
1 | 44 |
2 | 122 |
Clinical stage | |
II | 7 |
III | 166 |
Pretreatment CEA (ng/mL, median [range]) | 4 (0.6–306.6) |
Pretreatment CA199 (U/mL, median [range]) | 13.01 (0.75–1000) |
Posttreatment CEA (ng/mL, median [range]) | 2.5 (0.6–71.8) |
Posttreatment CA199 (U/mL, median [range]) | 11.66 (0–107.2) |
Concurrent chemotherapy | |
Capecitabine | 78 |
Capox | 95 |
CRM | |
Positive | 80 |
Negative | 93 |
EMVI | |
Positive | 86 |
Negative | 87 |
The neoadjuvant–surgery interval (day, median [range]) | 78 (46–227) |
The types of surgical procedures | |
Dixon | 152 |
Miles | 10 |
Hartmann | 2 |
Local excision | 9 |